https://www.prnewswire.com/news-releases/tsrl-inc-awarded-3m-nih-grant-to-continue-development-of-microneedle-patch-for-treatment-of-influenza-301066791.html
0
0
5/28/20 at 5:12am
Organization
PRNewswire
Authors
ANN ARBOR, Mich., May 28, 2020 /PRNewswire/ -- TSRL, Inc., announces the continued development of a transdermal delivery system of zanamivir (Relenza®), an inhalation drug product licensed for the treatment and prevention of influenza A & B. The project build…
Create an account
or login to join the discussion